The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Amethyst NSCLC trial: Phase 2, parallel-arm study of receptor tyrosine kinase (RTK) inhibitor, MGCD265, in patients (pts) with advanced or metastatic non-small cell lung cancer (NSCLC) with activating genetic alterations in mesenchymal-epithelial transition factor (MET).
 
Igor I. Rybkin
No Relationships to Disclose
 
Ebenezer A. Kio
No Relationships to Disclose
 
Ashiq Masood
Research Funding - AstraZeneca (Inst); Mirati Therapeutics (Inst)
 
Merrill Kingman Shum
No Relationships to Disclose
 
Balazs Halmos
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Celgene; Genentech/Roche
Research Funding - AstraZeneca; Boehringer Ingelheim; HealthCare Ventures; Merck; Mirati Therapeutics; Roche/Genentech
 
Collin M. Blakely
Research Funding - Clovis Oncology (Inst); Mirati Therapeutics (Inst)
Travel, Accommodations, Expenses - Ignyta
 
Keith D. Eaton
Research Funding - Mirati Therapeutics (Inst); Pfizer (Inst); Resolution Bioscience (Inst)
 
Neelesh Sharma
Stock and Other Ownership Interests - ARIAD; Idera; Intercept Pharmaceuticals; Opexa; Peregrine Pharmaceuticals; Synta
Research Funding - Astellas Pharma; Bristol-Myers Squibb; GlaxoSmithKline; Halozyme; ImmunoGen; Incuron; Mirati Therapeutics; NanoCarrier; Novartis
Travel, Accommodations, Expenses - Janssen; Novartis
 
John J. Nemunaitis
Employment - Gradalis
Leadership - Gradalis
Stock and Other Ownership Interests - Gradalis
Honoraria - Amgen
Consulting or Advisory Role - Amgen
Speakers' Bureau - Amgen
Patents, Royalties, Other Intellectual Property - Gradalis
Travel, Accommodations, Expenses - Amgen; Baxalta; Takeda
 
Steven J. Saccaro
No Relationships to Disclose
 
Yanis Boumber
Honoraria - AstraZeneca; PCE oncology; Synta
Consulting or Advisory Role - Bristol-Myers Squibb; Clovis Oncology
 
Raul R. Mena
No Relationships to Disclose
 
Hamid R. Mirshahidi
Consulting or Advisory Role - Clovis Oncology
 
Pasi A. Janne
Stock and Other Ownership Interests - GATEKEEPER Pharmaceuticals
Consulting or Advisory Role - ACEA Biosciences; AstraZeneca; Boehringer Ingelheim; Chugai Pharma; Merrimack; Pfizer; Roche
Research Funding - Astellas Pharma; AstraZeneca
Other Relationship - Dana-Farber Cancer Institute; LabCorp
 
James Christensen
Employment - Mirati Therapeutics
Leadership - Mirati Therapeutics
Stock and Other Ownership Interests - Mirati Therapeutics; Pfizer
Honoraria - Guardant Health
Consulting or Advisory Role - Guardant Health; Organovo
Patents, Royalties, Other Intellectual Property - Mirati Therapeutics; Pfizer
 
Richard C. Chao
Employment - Mirati Therapeutics
Stock and Other Ownership Interests - Merck; Mirati Therapeutics; Pfizer
 
Vanessa Roberts Tassell
Employment - Mirati Therapeutics
Stock and Other Ownership Interests - Aragon Pharmaceuticals; Mirati Therapeutics; Pfizer
 
Demiana Faltaos
Employment - Mirati Therapeutics
Stock and Other Ownership Interests - Arena Pharma; AstraZeneca; InVitae; Mirati Therapeutics
 
Marshall T. Schreeder
No Relationships to Disclose